Appco Pharma recalls

Appco Pharma has 6 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 8 Apr 2026. 3 are still ongoing. 3 were reported in the last 12 months. The most frequent reason is nitrosamine impurity.

Total recalls6since 2020

Last 12 months3reported

Class I00% of total

Ongoing3latest 8 Apr 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 1Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 3Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 5 83%Class III 1 17%

Why appco pharma is recalled

Nitrosamine Impurity583%
Other Reasons117%

Product types

Brands

Prazosin Hydrochloride350%
Venlafaxine117%

By year

2026350%
2025117%
2020233%

Ongoing appco pharma recalls

3 active

Reported	Class	Recall	Company	Reason	Where
8 Apr 2026Drug	CLASS II	Prazosin Hydrochloride Capsules, USP, 5mg recalled by Appco PharmaPrazosin Hydrochloride	Appco Pharma	Nitrosamine Impurity	Nationwide
8 Apr 2026Drug	CLASS II	Prazosin Hydrochloride Capsules, USP, 2mg recalled by Appco PharmaPrazosin Hydrochloride	Appco Pharma	Nitrosamine Impurity	Nationwide
8 Apr 2026Drug	CLASS II	Prazosin Hydrochloride Capsules, USP, 1mg recalled by Appco PharmaPrazosin Hydrochloride	Appco Pharma	Nitrosamine Impurity	Nationwide

All appco pharma recalls, newest first

6 total

Reported	Class	Recall	Company	Reason	Where
8 Apr 2026Drug	CLASS II	Prazosin Hydrochloride Capsules, USP, 5mg recalled by Appco PharmaPrazosin Hydrochloride	Appco Pharma	Nitrosamine Impurity	Nationwide
8 Apr 2026Drug	CLASS II	Prazosin Hydrochloride Capsules, USP, 2mg recalled by Appco PharmaPrazosin Hydrochloride	Appco Pharma	Nitrosamine Impurity	Nationwide
8 Apr 2026Drug	CLASS II	Prazosin Hydrochloride Capsules, USP, 1mg recalled by Appco PharmaPrazosin Hydrochloride	Appco Pharma	Nitrosamine Impurity	Nationwide
29 Jan 2025Drug	CLASS III	Venlafaxine Extended-Release Tablets, 150mg recalled by Appco PharmaVenlafaxine	Appco Pharma	Other	Nationwide
15 Jan 2020Drug	CLASS II	Ranitidine Capsules 150 mg, (a) bottles recalled by Appco Pharma	Appco Pharma	Nitrosamine Impurity	NJ
15 Jan 2020Drug	CLASS II	Ranitidine Capsules 300 mg recalled by Appco Pharma	Appco Pharma	Nitrosamine Impurity	NJ

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.